
    
      The aim of the present study was to compare the efficacy and tolerability of using lidocaine
      5% patch to 8% capsaicin patch in south Asian male patients with diabetic neuropathy.
      Assessment of analgesic effectiveness was assessed by observing any change in the Numeric
      Pain Rating Scale (NPRS) score, average daily pain Brief Pain Inventory (BPI) for painful
      diabetic peripheral neuropathy (BPI-DPN Q4) and Patient Global Impression of Change (PGIC).
      Assessment of capsaicin and lidocaine safety and identifying treatment adverse effects were
      secondary endpoints in this study
    
  